Ivana Krajsova

Ivana Krajsova

UNVERIFIED PROFILE

Are you Ivana Krajsova?   Register this Author

Register author
Ivana Krajsova

Ivana Krajsova

Publications by authors named "Ivana Krajsova"

Are you Ivana Krajsova?   Register this Author

14Publications

668Reads

49Profile Views

Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study.

Oncol Rep 2019 Sep 17. Epub 2019 Sep 17.

Department of Dermatovenereology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague 128 00, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2019.7319DOI Listing
September 2019

Clear cell sarcoma of vulva. A case report.

Cesk Patol 2016 ;52(4):215-217

View Article

Download full-text PDF

Source
September 2018

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

Eur J Cancer 2017 07 11;79:176-184. Epub 2017 May 11.

Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.007DOI Listing
July 2017

Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma.

Anticancer Res 2015 Nov;35(11):6303-10

Department of Oncology, Palacky University Medical School and University Hospital Olomouc, Olomouc, Czech Republic.

View Article

Download full-text PDF

Source
November 2015

Cultivation-dependent plasticity of melanoma phenotype.

Tumour Biol 2013 Dec 12;34(6):3345-55. Epub 2013 Jun 12.

1st Faculty of Medicine, Department of Dermatovenereology, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13277-013-0905-x
Publisher Site
http://dx.doi.org/10.1007/s13277-013-0905-xDOI Listing
December 2013

KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.

Melanoma Res 2005 Aug;15(4):251-6

Department of Oncology, First Faculty of Medicine, General Teaching Hospital, Charles University, Prague, Czech Republic.

View Article

Download full-text PDF

Source
August 2005